Eli Lilly Just Had a Setback. Is Its Stock Still a Buy? - Yahoo Finance

Mar 16, 2024 · Yahoo Finance Yahoo Finance . Search query. ... Eli Lilly Just Had a Setback. Is Its Stock Still a Buy? Alex Carchidi, The Motley Fool ... Eli Lilly had $34.1 billion in revenue. …

$34
OFF

Eli Lilly Just Had A Setback. Is Its Stock Still A Buy? - Yahoo Finance

2 weeks from now

Mar 16, 2024 · Yahoo Finance Yahoo Finance . Search query. ... Eli Lilly Just Had a Setback. Is Its Stock Still a Buy? Alex Carchidi, The Motley Fool ... Eli Lilly had $34.1 billion in revenue. …

yahoo.com

$34
OFF

Eli Lilly Just Had A Setback. Is Its Stock Still A Buy?

2 weeks from now

Mar 16, 2024 · In 2023, Eli Lilly had $34.1 billion in revenue. On average, analysts see its top line growing to $45 billion in 2025, of which $837 million is expected to be attributable to sales of …

theglobeandmail.com

61%
OFF

Eli Lilly Just Hit A Milestone That Disappointed. Here's Why You …

2 weeks from now

Nov 8, 2024 · Even a juggernaut like Eli Lilly (LLY 1.61%) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before …

fool.com

11%
OFF

Eli Lilly Just Hit A Milestone That Disappointed. Here's Why You

2 weeks from now

E ven a juggernaut like Eli Lilly (NYSE: LLY) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before recovering ...

msn.com

20%
OFF

Eli Lilly Just Got A Bundle Of Good News: Time To Buy?

2 weeks from now

Dec 4, 2024 · Plenty of reasons to buy. Eli Lilly's shares recently dropped after its third-quarter results did not meet expectations. The company's revenue increased by 20% year over year to …

fool.com

5%
OFF

Eli Lilly Shares Down 7.5% As Market Reacts To Slashed Q4 Forecast

2 weeks from now

12 hours ago · Shares of Eli Lilly are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024.The pharmaceutical giant expects …

yahoo.com

10%
OFF

Eli Lilly Falls More Than 10% In A Month: Buy, Sell Or Hold The Stock?

2 weeks from now

Nov 11, 2024 · Lilly’s stock has risen 42.7% so far this year compared with an increase of 11.6% for the industry. The stock has also outperformed the sector as well as the S&P 500, as seen …

nasdaq.com

6%
OFF

Eli Lilly Stock Down On Q4 Guidance Miss - Yahoo Finance

2 weeks from now

10 hours ago · Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. …

yahoo.com

17%
OFF

Eli Lilly Stock: 4 Reasons To Buy The Dip After A 17% Drop

2 weeks from now

1 day ago · Eli Lilly stock is down 17.75% from its highs as of Jan 10, 2025, even after authorizing a 15 billion stock buyback program. Sales of its GLP-1 drug, Mounjaro, surged 129% YoY in …

marketbeat.com

20%
OFF

Down More Than 20% From Its High, Is Now The Time To Buy Eli …

2 weeks from now

Nov 28, 2024 · Eli Lilly is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion. But in recent weeks, its share price has been falling. And …

nasdaq.com

58%
OFF

Up 58% YTD, Is Eli Lilly Stock Still A Buy? - Nasdaq

2 weeks from now

Aug 19, 2024 · The Street-high price target of $1,117 suggests that Eli Lilly stock could rise as much as 21.4% from here. At nearly 58x forward adjusted earnings, LLY stock is definitely …

nasdaq.com

$45
OFF

Eli Lilly: Still Expensive As Earnings Near, But Not Worthy Of A ...

2 weeks from now

3 days ago · Eli Lilly and Company. When it comes to the 2024 fiscal year in its entirety, management expects revenue to be between $45.4 billion and $46 billion. Even though this is …

seekingalpha.com

FAQs about Eli Lilly Just Had a Setback. Is Its Stock Still a Buy? - Yahoo Finance Coupon?

Is Eli Lilly (LLY) a buy?

Powered by its popular GLP-1 weight loss drugs, Eli Lilly 's stock (NYSE: LLY) has had a strong run this year, up more than 55%. However, the company's success goes back much further, with the stock up more than 1,300% over the past decade. Given its strong performance, investors may be wondering if the stock is still a buy. ...

Is Eli Lilly stock still worth buying?

Here's what happened and why Eli Lilly stock is still worth buying. First, the bad news: Lilly slightly cut its guidance for 2024. Whereas it previously anticipated bringing in as much as $46.6 billion in sales, it's now only expecting a max of $46 billion. ...

Why did Eli Lilly (LLY) stock trade down 6% Tuesday?

Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. Lilly revised its revenue guidance down 5%, to $13.5 billion, missing consensus of $14 billion by $500 million. ...

How much money will Eli Lilly make in 2023?

In 2023, Eli Lilly had $34.1 billion in revenue. On average, analysts see its top line growing to $45 billion in 2025, of which $837 million is expected to be attributable to sales of donanemab, or approximately 1.8% of total revenue. That's hardly an amount of sales to lose any sleep over. ...

Should you buy Eli Lilly (ell) now?

Eli Lilly Just Hit a Milestone That Disappointed. Here's Why You Should Still Buy the Stock. Eli Lilly's latest earnings report was not interpreted positively by the market. Its bestselling drugs reaching a point where supply is meeting demand was the issue. There is still a lot of upcoming growth priced into this stock's valuation. ...

Why are Eli Lilly shares down 76% today?

Shares of Eli Lilly (NYSE:LLY) are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024. The pharmaceutical giant expects only $13.5 billion in revenue for Q4 2024, compared to the consensus estimate of $13.97 billion. ...